Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 10, 2008, Pages 5434-5440

  Li, Feng ^a   Awale, Suresh ^a   Tezuka, Yasuhiro ^a   Kadota, Shigetoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Brazilian red propolis; Cytotoxic activity; Flavonoids; Structure activity relationship

Indexed keywords

7 HYDROXY 6 METHOXYFLAVANONE; BENZOFURAN DERIVATIVE; CHALCONE DERIVATIVE; DOXORUBICIN; FLAVONOID; FLAVONOL; FLUOROURACIL; ISOFLAVAN DERIVATIVE; ISOFLAVONE; LIGNAN; PROPOLIS; PTEROCARPAN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; FIBROSARCOMA; HELA CELL; HUMAN; HUMAN CELL; LEWIS CARCINOMA; MELANOMA B16; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAZIL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVANONES; FLAVONOIDS; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MOLECULAR STRUCTURE; NEOPLASMS; PROPOLIS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

MURINAE;

EID: 43749087342     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.04.016     Document Type: Article

References (32)

1. Banskota A.H., Tezuka Y., and Kadota S. Phytother. Res. 15 (2001) 561-571
2. Kumazawa S., Ueda R., Hamasaka T., Fukumoto S., Fujimoto T., and Nakayama T. J. Agric. Food Chem. 55 (2007) 7722-7725
3. Scazzocchio F., D'Auria F.D., Alessandrini D., and Pantanella F. Microbiol. Res. 161 (2006) 327-333
4. Kujumgiev A., Tsvetkova I., Serkedjieva Y., Bankova V., Christov R., and Popov S. J. Ethnopharmacol. 64 (1999) 235-240
5. Silici S., Koc N.A., Ayangil D., and Cankaya S. J. Pharmacol. Sci. 99 (2005) 39-44
6. Paulino N., Teixeira C., Martins R., Scremin A., Dirsch V.M., Vollmar A.M., Abreu S.R., de Castro S.L., and Marcucci M.C. Planta Med. 72 (2006) 899-906
7. Tan-No K., Nakajima K.T., Shoii T., Nakagawasai O., Niijima F., Ishikawa M., Endo Y., Sato T., Satoh S., and Tadano K. Biol. Pharm. Bull. 29 (2006) 96-99
8. Awale S., Li F., Onozuka H., Esumi H., Tezuka Y., and Kadota S. Bioorg. Med. Chem. 16 (2008) 181-189
9. de Barros M.P., Sousa J.P., Bastos J.K., and de Andrade S.F. J. Ethnopharmacol. 110 (2007) 567-571
10. Awale S., Shrestha S.P., Tezuka Y., Ueda J., Matsushige K., and Kadota S. J. Nat. Prod. 68 (2005) 858-864
11. Alencar S.M., Oldoni T.L., Castro M.L., Cabral I.S., Costa-Neto C.M., Cury J.A., Rosalen P.L., and Ikegaki M. J. Ethnopharmacol. 113 (2007) 278-283
12. Trusheva B., Popova M., Bankova V., Simova S., Marcucci M.C., Miorin P.L., da Rocha Pasin F., and Tsvetkova I. Evid. Based Complement. Alternat. Med. 3 (2006) 249-254
13. Pisco L., Kordian M., Peseke K., Feist H., Michalik D., Estrada E., Carvalho J., Hamilton G., Rando D., and Quincoces J. Eur. J. Med. Chem. 41 (2006) 401-407
14. Luo J., Soh J.W., Xing W.Q., Mao Y., Matsuno T., and Weinstein I.B. Anticancer Res. 21 (2001) 1665-1671
15. Than M.M., Banskota A.H., Tezuka Y., Midorikawa K., Matsushige K., and Kadota S. J. Trad. Med. 20 (2003) 20-29
16. Usia T., Banskota A.H., Tezuka Y., Midorikawa K., Matsushige K., and Kadota S. J. Nat. Prod. 65 (2002) 673-676
17. Banskota A.H., Nagaoka T., Sumioka L.Y., Tezuka Y., Awale S., Midorikawa K., Matsushige K., and Kadota S. J. Ethnopharmacol. 80 (2002) 67-73
18. Midorikawa K., Banskota A.H., Tezuka Y., Nagaoka T., Matsushige K., Message D., Huertas A.A.G., and Kadota S. Phytochem. Anal. 12 (2001) 366-373
19. Banskota A.H., Tezuka Y., Adnyana I.K., Midorikawa K., Matsushige K., Message D., Huertas A.A.G., and Kadota S. J. Ethnopharmacol. 72 (2000) 239-246
20. Banskota A.H., Tezuka Y., Prasain J.K., Matsushige K., Saiki I., and Kadota S. J. Nat. Prod. 61 (1998) 896-900
21. Ohnishi Y., Sakamoto T., Fujii H., Kimura F., Murata J., Tazawa K., Fujimaki M., Sato Y., Kondo M., Une Y., Uchino J., and Saiki I. Tumor Biol. 18 (1997) 113-122
22. Hart I.R. Am. J. Path. 97 (1979) 587-600
23. Aptekman P.M., and Lewis M.R. J. Immunol. 66 (1951) 361-364
24. Giard J.D., Aaronoson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., and Parks W.P. J. Natl. Cancer Inst. 51 (1973) 1417-1423
25. Gey G.O., and Coffman W.D. Cancer Res. 12 (1952) 264-265
26. Rasheed S., Nelson-Rees W.A., Thot E.M., Arnstein P., and Gardner M.B. Cancer 33 (1974) 1027-1033
27. Militão G.C., Dantas I.N., Pessoa C., Falcão M.J., Silveira E.R., Lima M.A., Curi R., Lima T., Moraes M.O., and Costa-Lotufo L.V. Life Sci. 78 (2006) 2409-2417
28. Pouge t.C., Lauthier F., Simon A., Fagnere C., Basly J.P., Delage C., and Chulia A.J. Bioorg. Med. Chem. Lett. 11 (2001) 3095-3097
29. Ducki S., Forrest R., Hadfield J.A., kendall A., Lawrence N.J., Mcgown A.T., and Rennison D. Bioorg. Med. Chem. Lett. 8 (1998) 1051-1056
30. Liu Y., Peterson D.A., Kimura H., and Schubert D. J. Neurochem. 69 (1997) 581-593
31. Banskota A.H., Tezuka Y., Prasain J.K., Matsushige K., Saiki I., and Kadota S. J. Nat. Prod. 61 (2005) 896-900
32. Saito K., Oku T., Ata N., Miyashiro H., Hattori M., and Saiki I. Biol. Pharm. Bull. 20 (1997) 345-348